3SBio: Is this Chinese Biotechnology Stock a Buy? - Barron's (blog)

Barron's (blog)
3SBio: Is this Chinese Biotechnology Stock a Buy?
Barron's (blog)
Shenyang-based 3SBio (1530.HK) is a biopharmaceutical pioneer that offers a unique play on China's rising demand for healthcare. The company is best known for its rheumatoid arthritis drug YSP, which accounts for 33% of revenues, and TPIAO, ...